PLOS

GE HealthCare Increases Access to Precision Care Tools, Encouraging the Continued Adoption and Practice of More Personalized Medicine Around the World

Retrieved on: 
Freitag, Juni 7, 2024

These shortfalls, in addition to ongoing healthcare resource and staff shortages,vi challenge the adoption of precision care globally.

Key Points: 
  • These shortfalls, in addition to ongoing healthcare resource and staff shortages,vi challenge the adoption of precision care globally.
  • GE HealthCare aims to design and develop a range of products that support these efforts, empowering global healthcare providers to address the needs of all patient populations.
  • GE HealthCare is also proud to offer global refurbished medical equipment, helping to improve access to affordable, quality healthcare.
  • GE HealthCare will also showcase these technologies and solutions at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2024 Annual Meeting in Toronto, Canada.

Twist Bioscience Publishes Preclinical Data Detailing Discovery of Antibody Targeting Emerging Checkpoint Inhibitor

Retrieved on: 
Donnerstag, Juni 6, 2024

The study titled, “ Discovery of a potent, selective, and tumor-suppressing antibody antagonist of adenosine A2A receptor ”, was published in the journal PLOS ONE.

Key Points: 
  • The study titled, “ Discovery of a potent, selective, and tumor-suppressing antibody antagonist of adenosine A2A receptor ”, was published in the journal PLOS ONE.
  • A2AR is an emerging immune checkpoint that plays a role in the immunosuppression of the tumor microenvironment.
  • “Using the ability to create large antibody libraries enabling discovery of novel and highly specific therapeutics, Twist has discovered an antibody that blocks A2AR, a promising checkpoint target and demonstrated its activity in preclinical models.
  • The antibody could be further developed as a standalone therapy, bispecific or combination therapy to bring potential therapeutic benefit to patients.”

GE HealthCare Pharmaco-Economic Study Demonstrates Adding Breast Oncology PET Tracer to Standard Workup of Patients with Metastatic or Recurrent Breast Cancer May Yield Beneficial Clinical and Economic Outcomes, Potentially Saving $142M Over Five...

Retrieved on: 
Dienstag, Juni 4, 2024

[18F]FES can be a powerful tool, providing high diagnostic accuracy in detection of estrogen receptor (ER)-positive lesions.

Key Points: 
  • [18F]FES can be a powerful tool, providing high diagnostic accuracy in detection of estrogen receptor (ER)-positive lesions.
  • The study demonstrated that adding a PET/CT scan with [18F]FES to biopsy/IHC may increase the diagnostic accuracy of the ER status in all appropriate patients with metastatic or recurrent breast cancer.
  • The clinical and economic benefits were especially pronounced in those situations where a tumor sample cannot be obtained, or the risk of a biopsy-related complication is high.
  • Cerianna is indicated for use with PET imaging for the detection of ER-positive lesions as an adjunct to biopsy in patients with metastatic and recurrent breast cancer.

Dogs Thrive on Vegan Diets, Demonstrates the Most Comprehensive Study So Far

Retrieved on: 
Dienstag, April 23, 2024

WINCHESTER, ENGLAND, Apr 24, 2024 - (ACN Newswire) - The longest, most comprehensive peer-reviewed study so far has demonstrated that dogs fed nutritionally-sound vegan diets maintain health outcomes as well as dogs fed meat.

Key Points: 
  • WINCHESTER, ENGLAND, Apr 24, 2024 - (ACN Newswire) - The longest, most comprehensive peer-reviewed study so far has demonstrated that dogs fed nutritionally-sound vegan diets maintain health outcomes as well as dogs fed meat.
  • The study was particularly interesting, given recent suggestions that peas might contribute to heart disease in dogs in the US.
  • In the current study, dogs were fed pea-based vegan pet food, for one year.
  • Our study offers new evidence on outcomes in clinically healthy dogs who thrive without consumption of animal-derived ingredients.

Sara Rouhi joins AIP Publishing as Director of Open Science and Publishing Innovation

Retrieved on: 
Dienstag, April 30, 2024

"AIPP has a storied history as researcher-focused non-profit committed to putting science first," Rouhi said. "I'm honored to join a leadership team not only committed to forging an equitable open science path but also deeply invested in building a workplace culture grounded in humility, experimentation, and embracing change. AIPP -- thanks to its cultural transformation and its open science investment -- stands poised to contribute meaningfully and substantively to the furthering of open science globally."

Key Points: 
  • MELVILLE, N.Y., April 30, 2024 /PRNewswire/ -- AIP Publishing (AIPP) announced today that Sara Rouhi has joined the organization in the new role of Director of Open Science and Publishing Innovation.
  • AIPP -- thanks to its cultural transformation and its open science investment -- stands poised to contribute meaningfully and substantively to the furthering of open science globally."
  • Rouhi joins AIP Publishing from Public Library of Science (PLOS) where she was Regional Director, Publishing Development, The Americas.
  • I'm thrilled that Sara will join us in driving open science innovation that truly benefits the physical sciences community."

OMRON Donates Some 3,200 Units of Blood Pressure Monitors to Global Blood Pressure Screening Campaign on World Hypertension Day

Retrieved on: 
Freitag, April 26, 2024

MMM was established by the International Society of Hypertension in 2017, and since then the Company has participated in this global campaign.

Key Points: 
  • MMM was established by the International Society of Hypertension in 2017, and since then the Company has participated in this global campaign.
  • May 17 is set to be the World Hypertension Day, and there are diverse events organized by regional societies and committees worldwide.
  • Blood pressure fluctuates throughout the day in response to a variety of factors such as temperature, humidity, and physical factors including stress.
  • Therefore, it is essential to monitor blood pressure at home in addition to regular health checkups at medical facilities.

OMRON Donates Some 3,200 Units of Blood Pressure Monitors to Global Blood Pressure Screening Campaign on World Hypertension Day

Retrieved on: 
Freitag, April 26, 2024

MMM was established by the International Society of Hypertension in 2017, and since then the Company has participated in this global campaign.

Key Points: 
  • MMM was established by the International Society of Hypertension in 2017, and since then the Company has participated in this global campaign.
  • May 17 is set to be the World Hypertension Day, and there are diverse events organized by regional societies and committees worldwide.
  • Blood pressure fluctuates throughout the day in response to a variety of factors such as temperature, humidity, and physical factors including stress.
  • Therefore, it is essential to monitor blood pressure at home in addition to regular health checkups at medical facilities.

Our laser technique can tell apart elephant and mammoth ivory – here’s how it may disrupt the ivory trade

Retrieved on: 
Donnerstag, April 25, 2024

In recent years, the global trade in elephant ivory has faced significant restrictions in an effort to protect dwindling elephant populations.

Key Points: 
  • In recent years, the global trade in elephant ivory has faced significant restrictions in an effort to protect dwindling elephant populations.
  • The sale of mammoth ivory, sourced primarily from long-extinct species, however, remains unregulated.
  • But it’s a significant challenge for customs and law enforcement agencies to distinguish between ivory from extinct mammoths and living elephants.
  • Now our new study, published in PLOS ONE, presents a major breakthrough – using a well known laser technique to tell mammoth and elephant ivory apart.


This activity not only has commercial implications. It also raises significant ethical and environmental concerns. That’s because it disturbs preserved ecosystems and involves the extraction of resources that have great value to paleontological science.

Laser insights

  • We use a non-invasive laser technique known as Raman spectroscopy to identify the origin of a piece of ivory.
  • The technique works by directing a laser light onto the ivory sample.
  • This released light scatters back with more or less energy than the initial laser light sent to the sample.

Important implications

  • This makes it an ideal tool for customs officials who need to make rapid decisions.
  • Our study was conducted on a benchtop spectrometer (a device which breaks up light by wavelength) within a laboratory.
  • We are working with Worldwide Wildlife Hong Kong and the Foreign and Commonwealth Development Office to develop this technique.


Rebecca Shepherd receives funding from EPSRC and the FCDO.

ACTREC Researchers Show Cancer Treatments May be Promoting its Spread

Retrieved on: 
Donnerstag, März 28, 2024

MUMBAI, India, March 28, 2024 /PRNewswire/ -- Cancer spreads from its primary tumor to other parts of the body via blood or the lymphatic system in a process termed 'metastasis'. This usually represents an advanced stage in the disease's progression and tends to be fatal. Therefore, preventing metastasis remains a major goal in oncology.

Key Points: 
  • In a step towards these efforts, Prof. Indraneel Mittra from the Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), India, has shed light on what causes metastasis.
  • Their findings, published in PLOS One result from experiments in mice grafted with human breast cancer cells (xenografts) to induce cancer.
  • Prof. Mittra concludes,"Future long-term experiments should explore whether cfChP-deactivating agents given concurrently with anti-cancer treatments could help prevent metastatic spread.
  • When used as adjuncts to cancer treatment, these agents would have the added advantage of preventing some of the toxic side effects of chemotherapy and radiotherapy."

ACTREC Researchers Show Cancer Treatments May be Promoting its Spread

Retrieved on: 
Donnerstag, März 28, 2024

MUMBAI, India, March 28, 2024 /PRNewswire/ -- Cancer spreads from its primary tumor to other parts of the body via blood or the lymphatic system in a process termed 'metastasis'. This usually represents an advanced stage in the disease's progression and tends to be fatal. Therefore, preventing metastasis remains a major goal in oncology.

Key Points: 
  • In a step towards these efforts, Prof. Indraneel Mittra from the Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), India, has shed light on what causes metastasis.
  • Their findings, published in PLOS One result from experiments in mice grafted with human breast cancer cells (xenografts) to induce cancer.
  • Prof. Mittra concludes,"Future long-term experiments should explore whether cfChP-deactivating agents given concurrently with anti-cancer treatments could help prevent metastatic spread.
  • When used as adjuncts to cancer treatment, these agents would have the added advantage of preventing some of the toxic side effects of chemotherapy and radiotherapy."